SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 81.77 |
| Enterprise Value ($M) | 84.18 |
| Book Value ($M) | -11.31 |
| Book Value / Share | -0.71 |
| Price / Book | -7.23 |
| NCAV ($M) | -18.80 |
| NCAV / Share | -1.18 |
| Price / NCAV | -4.35 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.52 |
| Return on Assets (ROA) | -2.12 |
| Return on Equity (ROE) | -10.66 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.80 |
| Current Ratio | 1.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 20.69 |
| Assets | 28.18 |
| Liabilities | 39.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -44.99 |
| Net Income | -51.90 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -37.07 |
| Cash from Investing | -0.08 |
| Cash from Financing | 42.32 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Yekaterina Chudnovsky | 48.10 | ||
| 13G | Knoll Capital Management, LLC | 5.20 | ||
| 13G | Actyus Private Equity SGIIC, S.A. | 5.45 | ||
| 13D/A | Gkcc, Llc | 38.70 | 159.90 | |
| 13D/A | Clal Biotechnology Industries Ltd. | 4.68 | -19.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,700 | 27,543 | 17.06 | |
| 8,145 | 37,463 | 21.74 | |
| 24,997 | 115,634 | 21.62 | |
| 18,220 | 103,665 | 17.58 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EDSA – Edesa Biotech, Inc. | ELDN – Eledon Pharmaceuticals, Inc. |
| ELEV – Elevation Oncology, Inc. | ELUT – Elutia Inc. |
| ENLV – Enlivex Therapeutics Ltd. |
Financial data and stock pages provided by
Fintel.io